Modulating the pulmonary circulation: An update

Minerva Anestesiologica

Volumn 70, Issue 4, 2004, Pages 239-243

  Dembinski, R ^a   Henzler, D ^a   Rossaint, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Pulmonary hypertension, diagnosis; Pulmonary hypertension, therapy; Vasodilators

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; VASODILATOR AGENT;

ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; GAS EXCHANGE; HEART AFTERLOAD; HEART DISEASE; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPOTENSION; HYPOXEMIA; LUNG CIRCULATION; LUNG DISEASE; LUNG SHUNTING; LUNG VENTILATION PERFUSION RATIO; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; RISK FACTOR; SYSTEMIC DISEASE; THORAX SURGERY; TREATMENT OUTCOME; VASODILATATION;

HUMANS; HYPERTENSION, PULMONARY; LUNG; PULMONARY CIRCULATION; VASODILATOR AGENTS;

EID: 3142777206     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM et al. Primary Pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
2. Strange JW, Wharton J, Phillips PG, Wilkins MR. Recent insights into the pathogenesis and therapeutics of pulmonary hypertension. Clin. Sci. (Lond) 2002;102: 253-68.
3. Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM, Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 199;89:814-22.
4. Koul B, Wollmer P, Willen H, Kugelberg J, Steen S. Venoarterial extracorporeal membrane oxygenation - how safe is it? Evaluation with a new experimental model. J Thorac Cardiovasc Surg 1992;104:579-84.
5. Von Dossow V, Welte M, Zaune U, Martin E, Walter M, Ruckert J et al. Thoracic epidural anesthesia combined with general anesthesia: the preferred anesthetic technique for thoracic surgery. Anesth Analg 2001;92: 848-54.
6. Sitbon O, Humbert M, Simonneau G. Primary pulmonary hypertension: Current therapy. Prog Cardiovasc Dis 2002;45:115-28.
7. Alpert MA, Pressly TA, Mukerji V, Lambert CR, Mukerji B. Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease. Chest 1992;102: 1407-12.
8. Alpert MA, Pressly TA, Mukerji V, Lambert CR, MUkerji B, Panayiotou H, Sharp GC. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. Am J Cardiol 1991;68:1687-91.
9. Jenkins IR, Dolman J, O'Connor JP, Ansley DM. Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial. Anaesth Intensive Care 1997;25:245-9.
10. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
11. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993;342:961-2.
12. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Critter GJ et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group, Crit Care Med 1998;26: 15-23.
13. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999;25:911-9.
14. Michael JR, Barton RG, Saffle JR, Mone M, Markewitz BA, Hillier K, et al. inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157:1372-80.
15. Troncy E, Collet JP, Shapiro S, Guimond JG, Blair L, Ducruet T, et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled Study. Am J Respir Crit Care Med 1998;157:1483-8.
16. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996;347:436-40.
17. Ewert R, Wensel R, Opitz CF. Aerosolized iloprost for primary Pulmonary hypertension. N Engl J Med 2000;343:1421-2.
18. Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 2000;342:1866-70.
19. Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Willbruck B, Grimminger F et al. inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 1999;160:600-7.
20. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88:2128-38.
21. Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe Pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995;73:65-8.
22. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J. Thorac. Cardiovasc. Surg. 1994;107:1129-35.
23. Adatia I, Lillehei C, Arnold JH, Thompson JE, Palazzo R, Fackler JC et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57:1311-8.